Home
Chase & Co Jpmorgan reported a 0.2% stake in Keros Therapeutics KROS · 113,803 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 0.2%
- Last report
- 6.3% · filed 25/05/02
- Shares held
- 113,803 sh
- Class
- Common Stock, $0.0001 par value per share
- Holder
- Chase & Co Jpmorgan
- Event date
- 25/04/30
- Filed
- 25/05/05
0.2% stake · below 5%
- Stake
- 0.2%
- Last report
- 6.3%
- Since last report
- −6.1pp
Keros Therapeutics trades, last 26 weeks
What else happened in Keros Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/31~25/05/30Chase & Co Jpmorgan's other 5% stake reports
- Chase & Co Jpmorgan
5% stakeBlackrock Muniholdings Fund
5% stakeBlackrock Muniholdings Fund
MHD
100% stake
7,178 sh
100% stake
Filed 10/01
- Chase & Co Jpmorgan
5% stakeCiena
5% stakeCiena
CIEN
3.9% stake
5,616,378 sh
3.9% stake
Filed 09/03
- Chase & Co Jpmorgan
5% stakeVicor
5% stakeVicor
VICR
4% stake
1,394,339 sh
4% stake
Filed 09/03
- Chase & Co Jpmorgan
5% stakeMKS
5% stakeMKS
MKSI
2.9% stake
2,005,756 sh
2.9% stake
Filed 09/03
- Chase & Co Jpmorgan
5% stakeLamb Weston Holdings
5% stakeLamb Weston Holdings
LW
4.9% stake
6,889,942 sh
4.9% stake
Filed 08/05
